ENTity USB Videoscope System
Optim, LLC · Decision date May 14, 2026
What did the FDA decide?
FDA records K254133 as a 510(k) premarket notification, with a decision dated May 14, 2026. The decision code SESE records a finding of substantial equivalence. This is a 510(k) clearance.
- Regulatory pathway
- 510(k) premarket notification
- Clinical specialty
- Ear, Nose, Throat
- Decision date
- May 14, 2026
Regulatory record facts
- Identifier
- K254133
- Regulatory pathway
- 510(k) premarket notification
- Applicant
- Optim, LLC
- Product code
- EOB
- Decision code
- SESE
- Decision date
- May 14, 2026
- Source update
- Nov 9, 2026
- Original record
- Open FDA source record
About this medical device
FDA device category: Nasopharyngoscope (Flexible Or Rigid).
- Applicant
- Optim, LLC
- Product code
- EOB
- FDA device class
- 2
FDA decision timeline
K254133 received
Application receipt date recorded by FDA.
K254133 · FDA decision
SESE
Related devices and submissions
Explore the linked device profile
Other records with product code EOB
| Product / regulatory record | Company | Pathway | Decision date | Source |
|---|---|---|---|---|
| Karl Storz SE & CO. KG | 510(k) clearance | Sep 15, 2026 | FDA | |
Hydro Irrigation SystemK261544 | Stryker Instruments | 510(k) clearance | Jun 17, 2026 | FDA |
| Zhuhai Wesee Meditech Co., Ltd. | 510(k) clearance | Mar 25, 2026 | FDA | |
| Olympus Medical Systems Corporation | 510(k) clearance | Mar 20, 2026 | FDA |
A shared product code identifies a classification relationship; it does not establish clinical equivalence.
Regulatory context
A 510(k) submission seeks a finding of substantial equivalence to a legally marketed device. A clearance and a PMA approval are different regulatory decisions.
Read our guide to FDA clearance and approval · FDA’s explanation of this pathway
Manufacturer intelligence
Optim, LLC
- Headquarters
- Not reported
- Brand website
- Not reported
- FDA applicant address
- Sturbridge, MA
Sources and methodology
- Original FDA record: K254133
- openFDA source data · Source release Nov 9, 2026 · Retrieved Nov 20, 2026
FDA fields and approval-order wording are presented as source information. MedtechLedger explanations are identified separately and describe the scope of the recorded decision. Indications from an original PMA are historical unless confirmed against subsequent labeling and supplements.
How we use FDA records


